Teleflex Incorporated (TFX) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

Total Revenue Chart for Teleflex Incorporated

Teleflex Incorporated (TFX) revenue for FY2025 was USD 2.0B, a -34.6% change from FY2024. Teleflex Incorporated's revenue grew from USD 171.8M in 1985 to USD 2.0B in 2025 (1059.9% over 40 years). Earnings per share grew from USD 2.83 in 2000 to USD -20.25 in 2025 (-815.5%). Revenue compound annual growth rate: 5-year CAGR of -4.7%, 10-year CAGR of 1.0%, 20-year CAGR of -1.2%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$5.77B
Implied Share Price
$136.29
Enterprise Value
$7.86B
Revenue (TTM)
$2.25B
EBITDA
$403.90M
Profit Margin
-45.76%
Trailing P/E
—
Forward P/E
11.01
Price/Book (MRQ)
1.82
Price/Sales (TTM)
2.56
EV/EBITDA
30.73
EV/Revenue
3.49
Dividend Yield
1.00%
Book Value
$68.55
Free Cash Flow (FY2025)
$245.44M
Free Cash Flow Yield
4.25%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.